NCT06422884: A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
- State
- Completed
- Phase
- Phase 2
- People
- 213 taking part
- Started
- 15 Nov 2024
- Primary completion
- 21 Aug 2026
- Arms
- ENV-101 Low Dose (IPF Population), ENV-101 Mid Dose (IPF Population), ENV-101 High Dose (IPF Population)
- Results
- None posted
- 21 May 2024: Trial registered
- 15 Nov 2024: Trial started
- 21 Aug 2026: Trial completed